Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T4IW
|
|||
| Former ID |
DNCL002221
|
|||
| Drug Name |
8H9 I-131 mab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Leptomeningeal sarcoma [ICD-11: 2A01.0; ICD-10: C70] | Phase 2 | [1] | |
| Small round cell desmoplastic tumour [ICD-11: 2A20.5; ICD-10: C49; ICD-9: 171] | Phase 1/2 | [1] | ||
| Peritoneal cancer [ICD-11: 2C51.Z] | Phase 1 | [2] | ||
| Soft tissue sarcoma [ICD-11: 2B57] | Phase 1 | [2] | ||
| Company |
United Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT00582608) Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.